MANKIND.NS
MANKIND.NS
INE634S01028
MANKIND PHARMA LIMITED
Loading chart...

Company Profile

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural and pet food products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Telmikind-Am, Gudcef, Glimestar-M, Candi Force, Nurokind-Gold, Telmikind-H, Telmikind, Nurokind-Lc, Nurokind Plus-Rf, Vomikind, Cefakind, Glizid-M, Monticope, and Gudcef-Cv brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.

Related stocks

ZYDUSLIFE.NS
ZYDUSLIFE.NS • India
ZYDUS LIFESCIENCES LTD
1,117.5 INR
11.52B USD 1Y +12.8%
LAURUSLABS.NS
LAURUSLABS.NS • India
LAURUS LABS LIMITED
2,036.6 INR
11.37B USD 1Y +135.4%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%
CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
AUROPHARMA.NS
AUROPHARMA.NS • India
AUROBINDO PHARMA LTD
1,693 INR
10.07B USD 1Y +51.2%
ALKEM.NS
ALKEM.NS • India
ALKEM LABORATORIES LTD.
5,279 INR
6.52B USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
29.9% p.a.
Max Drawdown (3Y)
-35.7%
Sharpe Ratio (3Y)
0.27
Beta Factor
0.45
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 50.3 (Elevated multiple compression risk)
ende